DENTSPLY SIRONA Inc. (XRAY) stock analysis

XRAY · DENTSPLY SIRONA Inc.

Latest recorded price: USD 8.94

Model-estimated fair value: USD 7.75. This assumption-based estimate is for general research and is not investment advice.

Sector and industry: Healthcare · Medical Instruments & Supplies

At $8.94, XRAY trades 15.4% above the model's base-case value of $7.75. Using FCFF DCF, the model estimates $4.56 in the conservative case and $15.75 in the optimistic case, with a valuation confidence score of 85/100. About 73% of the value comes from the terminal value, so the result is sensitive to long-term growth and discount-rate assumptions. Fiscal 2025 figures: revenue growth -2.1%, free cash flow margin 2.8%, ROIC -10.0%. The model flags 2 risk signals for this company (1 high severity).

Similar companies in Healthcare